 | • レポートコード：MRC2203A054 • 出版社/出版日：Mordor Intelligence / 2022年1月 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療 |
| Single User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Site Licence | ￥962,000 (USD6,500) | ▷ お問い合わせ |
| Corporate License | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Mordor Intelligence社は、世界の乳房再建市場規模が、年平均7.1％成長すると予測しています。本市場調査レポートでは、乳房再建の世界市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、製品別（豊胸手術、組織エキスパンダー、無細胞真皮マトリックス、その他）分析、エンドユーザー別（病院、外来診療センター、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米）分析、競争状況、市場機会・将来傾向など、以下の構成でまとめました。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・世界の乳房再建市場規模：製品別（豊胸手術、組織エキスパンダー、無細胞真皮マトリックス、その他） ・世界の乳房再建市場規模：エンドユーザー別（病院、外来診療センター、その他） ・世界の乳房再建市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米） ・競争状況（Allergan Plc、Sientra, Inc、IDEAL IMPLANT INCORPORATED、…） ・市場機会・将来傾向 |
The breast reconstruction market studied was projected to grow with a CAGR of nearly 7.1% over the forecast period. The major factor attributing to the growth of the market is the increasing incidence of breast cancer. According to the World Health Organization, breast cancer is the most common cancer among women, impacting 2.1 million women every year, and also affects the greatest number of cancer-related deaths among women. In 2018, it is estimated that 627,000 women died from the breast cancer. Furthermore, increasing awareness about the safety of breast reconstruction options is reassuring women undergoing mastectomy and other breast cancer surgeries to choose the reconstruction process. The increasing products with advanced technologies are boosting the market growth. However, the high cost of the breast reconstruction procedures is the major factor restrining growth of the market.
Key Market Trends
Breast Implants Holds the Largest Share in the Breast Reconstruction Market.
- The inclusion of breast implants in breast reconstruction surgeries accounted for over a major share of the global market, and this is expected to remain a prominent trend in the breast reconstruction space in the forecast period. The implants are either saline or silicone implants.
- An increase in the number of breast surgeries that are proportional to the growing incidence of breast cancer is propelling segment growth. According to the International Society of Aesthetic Plastic Surgery, 1540289 breast augmentation procedures that involve implants were performed in 2017. As the number of procedures increase the growth of the segment increases.
- Thus, considering all the above mentioned factors the market is expected to witness high growth over the forecast period.
North America Dominates the Market and Expected to do Same in the Forecast Period
North America is expected to dominate the overall market, throughout the forecast period. The market growth is due to the factors such as the high incidence of breast cancer and increasing breast augmentation procedures, established healthcare infrastructure are some of the key factors accountable for its large share in the market. According to the American Cancer Society, in 2017, an estimated 252,710 new cases of invasive breast cancer were diagnosed among women. Furthermore, beneficial government initiatives and an increase in the number of research partnerships are some of the drivers expected to increase market growth. The rising focus of market players in the United States and increasing prevalence of breast cancer are likely to boost the growth of the breast reconstruction market in North America.
Competitive Landscape
The breast reconstruction market is moderately competitive and consists of several major players. Some of the companies which are currently dominating the market are Allergan, Sientra, Inc, IDEAL IMPLANT INCORPORATED, Johnson & Johnson, Establishment Labs S.A., POLYTECH Health & Aesthetics GmbH, RTI Surgical, Inc., Groupe Sebbin SAS, Integra LifeSciences, GC Aesthetics.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Incidence of Breast Cancer
4.2.2 Introduction of Technologically Advanced Products
4.3 Market Restraints
4.3.1 High Cost of Breast Reconstruction Procedures
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product
5.1.1 Breast Implants
5.1.2 Tissue Expanders
5.1.3 Acellular Dermal Matrices
5.1.4 Other
5.2 By End-User
5.2.1 Hospitals
5.2.2 Ambulatory Care Centers
5.2.3 Other
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle-East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle-East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Allergan Plc
6.1.2 Sientra, Inc
6.1.3 IDEAL IMPLANT INCORPORATED
6.1.4 Johnson & Johnson
6.1.5 Establishment Labs S.A.
6.1.6 POLYTECH Health & Aesthetics GmbH
6.1.7 RTI Surgical, Inc.
6.1.8 Groupe Sebbin SAS
6.1.9 Integra LifeSciences
6.1.10 GC Aesthetics
7 MARKET OPPORTUNITIES AND FUTURE TRENDS